Clinical trial • Phase II • Other
Ketamine for Healthy volunteers
Phase II trial of Ketamine for Healthy volunteers. 12 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- Healthy volunteers
- Trial Stage
- Phase II
- Drug Modality
- Small molecule
Key dates
- Initial CTIS Submission Date
- 05-11-2025
- First CTIS Authorization Date
- 16-02-2026
Trial design
Phase II trial across 1 site in Finland.
- Target Sample Size
- 12
Eligibility
Recruits 12 Vulnerable population not selected; study population listed as healthy volunteers; no additional consent or assent details provided..
- Vulnerable Population
- Vulnerable population not selected; study population listed as healthy volunteers; no additional consent or assent details provided.
Recruitment
- Planned Sample Size
- 12
- Recruitment Window Months
- 10
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 12
Finland
- Earliest CTIS Part Ii Submission Date
- 23-01-2026
- Latest Decision Or Authorization Date
- 23-02-2026
- Processing Time Days
- 31
- Number Of Sites
- 1
- Number Of Participants
- 12
Sites
- Site Name
- HUS-yhtymae
- Department Name
- Kliininen farmakologia
- Contact Person Name
- Janne Backman
- Contact Person Email
- janne.backman@hus.fi
- Number Of Participants
- 12
Sponsor
Primary sponsor
- Full Name
- HUS-yhtymae
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Finland
Investigational products
- Investigational Product Name
- Ketamine
- Active Substance
- Ketamine
- Modality
- Small molecule
- Investigational Product Name
- Cannabidiol
- Active Substance
- Cannabidiol
- Modality
- Small molecule
- Investigational Product Name
- Cobicistat
- Active Substance
- Cobicistat
- Modality
- Small molecule
Related trials
Other published trials that may interest you.